Related Experiment Video
Updated: Jan 21, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys
Haiyan Chu1, Jonathan M Shillingford1, Joseph A Reddy1
1Endocyte, Inc. , 3000 Kent Avenue, Suite A1-100 , West Lafayette , Indiana 47906 , United States.
Abstract:
Folate-based small molecule drug conjugates (SMDCs) are currently under development and have shown promising preclinical and clinical results against various cancers and polycystic kidney disease. Two requisites for response to a folate-based SMDC are (i) folate receptor alpha (FRα) protein is expressed in the diseased tissues, and (ii) FRα in those tissues is accessible and functionally competent to bind systemically administered SMDCs. Here we report on the development of a small molecule reporter conjugate (SMRC), called EC2220, which is composed of a folate ligand for FRα binding, a multilysine containing linker that can cross-link to FRα in the presence of formaldehyde fixation, and a small hapten (fluorescein) used for immunohistochemical detection. Data show that EC2220 produces a far greater IHC signal in FRα-positive tissues over that produced with EC17, a folate-fluorescein SMRC that is released from the formaldehyde-denatured FRα protein. Furthermore, the extent of the EC2220 IHC signal was proportional to the level of FRα expression. This EC2220-based assay was qualified both in vitro and in vivo using normal tissue, cancer tissue, and polycystic kidneys. Overall, EC2220 is a sensitive and effective reagent for evaluating functional and accessible receptor expression in vitro and in vivo.
Insights
A new reagent, EC2220, effectively detects functional folate receptor alpha (FRα) expression in tissues. This small molecule reporter conjugate (SMRC) enables sensitive assessment for targeted cancer and kidney disease therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Folate-based small molecule drug conjugates (SMDCs) show promise for treating cancers and polycystic kidney disease.
- Effective use of SMDCs requires folate receptor alpha (FRα) expression in target tissues.
- Assessing FRα accessibility and functionality is crucial for SMDC efficacy.
Purpose of the Study:
- To develop a novel small molecule reporter conjugate (SMRC) for evaluating FRα.
- To assess the sensitivity and effectiveness of the SMRC in detecting FRα expression.
- To validate the SMRC for both in vitro and in vivo applications.
Main Methods:
- Development of EC2220, a folate-ligand based SMRC with a multilysine linker and fluorescein hapten.
- Immunohistochemical (IHC) detection of FRα using EC2220 and comparison with EC17.
- In vitro and in vivo qualification of the EC2220-based assay using normal, cancer, and polycystic kidney tissues.
Main Results:
- EC2220 generated a significantly stronger IHC signal than EC17 in FRα-positive tissues.
- The EC2220 IHC signal intensity correlated with the level of FRα expression.
- The EC2220 assay demonstrated sensitivity and effectiveness in vitro and in vivo.
Conclusions:
- EC2220 is a sensitive and effective reagent for assessing FRα expression.
- This SMRC allows for the evaluation of functional and accessible FRα in various tissues.
- EC2220 can aid in patient selection for folate-targeted therapies.
More Related Videos
10:51A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Kidney Structure
Internal Receptors
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...